Zobrazeno 1 - 10
of 41 094
pro vyhledávání: '"meningococcal"'
Autor:
Ahmed T; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh; Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada., Tauheed I; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Hoque S; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Sarower Bhuyan G; Institute for Developing Science & Health Initiatives (ideSHi), Dhaka, Bangladesh., Biswas R; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Tarikul Islam M; Institute for Developing Science & Health Initiatives (ideSHi), Dhaka, Bangladesh; Postdoctoral Research Associate, Washington University in St. Louis, USA., Islam S; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Amir Hossain M; Institute for Developing Science & Health Initiatives (ideSHi), Dhaka, Bangladesh., Ahmmed F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Muktadir A; Incepta Vaccine Limited, Dhaka, Bangladesh., Muktadir H; Incepta Vaccine Limited, Dhaka, Bangladesh., Ahmed F; Incepta Vaccine Limited, Dhaka, Bangladesh., Karim M; Incepta Vaccine Limited, Dhaka, Bangladesh., Panday AS; Incepta Vaccine Limited, Dhaka, Bangladesh., Kundu Tanu T; Incepta Vaccine Limited, Dhaka, Bangladesh., Muktadir Rahman Ashik M; Incepta Vaccine Limited, Dhaka, Bangladesh., Rahad Hossain M; Incepta Vaccine Limited, Dhaka, Bangladesh., Shariful Bari S; Incepta Vaccine Limited, Dhaka, Bangladesh., Ahmed R; Incepta Vaccine Limited, Dhaka, Bangladesh., Masudur Rahman Mia M; Incepta Vaccine Limited, Dhaka, Bangladesh., Islam S; Incepta Vaccine Limited, Dhaka, Bangladesh., Khan I; Incepta Vaccine Limited, Dhaka, Bangladesh., Mainul Ahasan M; Incepta Vaccine Limited, Dhaka, Bangladesh., Chowdhury F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Rahman Bhuiyan T; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Islam Chowdhury M; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh., Qadri F; International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh. Electronic address: fqadri@icddrb.org.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126063. Date of Electronic Publication: 2024 Jun 18.
Autor:
Wang B; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia., Mohammed H; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia., Andraweera P; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia., McMillan M; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia., Marshall H; Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia. Electronic address: helen.marshall@adelaide.edu.au.
Publikováno v:
The Journal of infection [J Infect] 2024 Sep; Vol. 89 (3), pp. 106225. Date of Electronic Publication: 2024 Jul 08.
Autor:
Calvert A; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK acalvert@sgul.ac.uk.; St George's University Hospitals NHS Foundation Trust, London, UK., Andrews N; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Barlow S; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Borrow R; Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Black C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bromage B; Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK., Carr J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Monash University, Clayton, Victoria, Australia., Clarke P; Neonatal Intensive Care Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.; Norwich Medical School, University of East Anglia, Norwich, UK., Collinson AC; Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, UK., Few K; Neonatal Intensive Care Unit, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK., Hayward N; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK., Jones CE; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.; NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Le Doare K; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; Makerere University Johns Hopkins University, Kampala, Uganda.; Pathogen Immunology Group, UK Health Security Agency, Salisbury, UK., Ladhani SN; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK., Louth J; Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Papadopoulou G; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Pople M; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Scorrer T; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Snape MD; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Heath PT; Centre for Neonatal and Paediatric Infection and Vaccine Institute, St George's, University of London, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
Archives of disease in childhood [Arch Dis Child] 2024 Oct 18; Vol. 109 (11), pp. 898-904. Date of Electronic Publication: 2024 Oct 18.
Autor:
Taha S; Institut Pasteur, Université Paris Cité, unité des infections bactériennes invasives et Centre national de référence des méningocoques et Haemophilus influenzae, Paris, France., Deghmane AE; Institut Pasteur, Université Paris Cité, unité des infections bactériennes invasives et Centre national de référence des méningocoques et Haemophilus influenzae, Paris, France.
Publikováno v:
La Revue du praticien [Rev Prat] 2024 Oct; Vol. 74 (8), pp. s7-s10.
Autor:
Voltolini A; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Marcotrigiano V; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Cian S; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Fiorito N; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Sollano A; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Dall'O I; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Battistin M; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Bino E; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Lovat A; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., D'Incà P; Communication Office, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy., Baldovin T; Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padova, Italy., Baldo V; Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padova, Italy., Cinquetti S; Prevention Department, Local Health Authority 'Azienda ULSS 1 Dolomiti', Belluno, Italy.
Publikováno v:
Annali di igiene : medicina preventiva e di comunita [Ann Ig] 2024 Nov-Dec; Vol. 36 (6), pp. 703-711. Date of Electronic Publication: 2024 May 02.
Autor:
Haas H; Centre hospitalier Princesse-Grace, Monaco. Centre hospitalier universitaire de Nice, hôpital Archet 2, Nice, France. Groupe de pathologie infectieuse pédiatrique, France., Caseris M; Hôpital universitaire Robert-Debré, Paris, France. Groupe de pathologie infectieuse pédiatrique, France.
Publikováno v:
La Revue du praticien [Rev Prat] 2024 Oct; Vol. 74 (8), pp. s11-s13.
Autor:
Rani S; Department of Community Health & Epidemiology, College of Medicine (Rani, Hasselback), University of Saskatchewan; Saskatchewan Health Authority (Rani, Hasselback), Idylwyld Centre, Saskatoon, Sask.; School of Nursing, Faculty of Health Sciences (Coletto), University of Ottawa, Ottawa, Ont. savita.rani@usask.ca., Coletto S; Department of Community Health & Epidemiology, College of Medicine (Rani, Hasselback), University of Saskatchewan; Saskatchewan Health Authority (Rani, Hasselback), Idylwyld Centre, Saskatoon, Sask.; School of Nursing, Faculty of Health Sciences (Coletto), University of Ottawa, Ottawa, Ont., Hasselback J; Department of Community Health & Epidemiology, College of Medicine (Rani, Hasselback), University of Saskatchewan; Saskatchewan Health Authority (Rani, Hasselback), Idylwyld Centre, Saskatoon, Sask.; School of Nursing, Faculty of Health Sciences (Coletto), University of Ottawa, Ottawa, Ont.
Publikováno v:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2024 Sep 15; Vol. 196 (30), pp. E1041. Date of Electronic Publication: 2024 Sep 15.
Autor:
Robertson CA; Global Medical Affairs, Sanofi, Swiftwater, PA, USA., Jacqmein J; Jacksonville Center for Clinical Research, Jacksonville, FL, USA., Selmani A; Biostatistics, Sanofi, Swiftwater, PA, USA., Galarza K; Scientific & Medical Affairs, Sanofi, Swiftwater, PA, USA., Oster P; Global Medical Affairs, Sanofi, Lyon, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2426868. Date of Electronic Publication: 2024 Nov 18.
Autor:
Clark SA; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Willerton L; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK., Claus H; National Reference Centre for Meningococci and Haemophilus Influenzae, Institute for Hygiene and Microbiology, Julius-Maximilian University of Wuerzburg, Wuerzburg, Germany., Carannante A; Department Infectious Diseases, Instituto Superiore di Sanità, Rome, Italy., Stefanelli P; Department Infectious Diseases, Instituto Superiore di Sanità, Rome, Italy., Abad R; Reference Laboratory for Meningococci, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Vázquez JA; Reference Laboratory for Meningococci, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Borrow R; Meningococcal Reference Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2427471. Date of Electronic Publication: 2024 Nov 13.
Autor:
Tsang RSW; Vaccine Preventable Bacterial Disease, Reference Science and Surveillance Directorate, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. Electronic address: raymond.tsang@phac-aspc.gc.ca., Deceuninck G; Axe Maladies infectieuses et immunitaires, Centre de recherche du CHU de Québec - Université Laval, Québec City, Québec, Canada; Direction des risques biologiques, Institut National de Santé Publique du Québec, Québec City, Québec, Canada., Meilleur C; Vaccine Preventable Bacterial Disease, Reference Science and Surveillance Directorate, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Zhou J; Vaccine Preventable Bacterial Disease, Reference Science and Surveillance Directorate, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Lefebvre B; Laboratoire de santé publique du Québec, Institut nationale de sante publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada., De Wals P; Department of Social and Preventive Medicine, Laval University, Québec City, Québec, Canada.
Publikováno v:
The Journal of infection [J Infect] 2024 Jun; Vol. 88 (6), pp. 106163. Date of Electronic Publication: 2024 Apr 24.